Late in January the company also pled guilty to a misdemeanor for promoting Zyprexa to the elderly as a treatment for Alzheimer's even though the drug isn't approved by the FDA for such uses. As part of the guilty plea, Lilly must also pay a fine and forfeiture of $615 million, $438 million to the federal government, and $362 million to the settling states.
Thousands of plaintiffs have also brought individual suits against Eli Lilly, many accusing the company of failing to provide adequate warnings that the drug may cause weight gain and diabetes.
In addition Lilly has been sued by insurance companies and other organizations for breaking marketing laws and overcharging for the drugs.
 Daly, E. "Lilly Officially Pleads Guilty In Zyprexa Debacle," Law360 (January 30, 2009).
 USA v. Eli Lilly & Co., Case No. 2:09-cr-00020,United States District Court for the Eastern District of Pennsylvania.